Among the 14 patients in group A, the frequent TRAEs during or after concurrent RT with atezo-bev were increased AST (35.7%), anorexia or nausea (28.6%), dermatitis (28.6%), fatigue (21.4%), increased ALT (21.4%), hypertension (21.4%), pyrexia (14.3%), proteinuria (14.3%), and radiation-related gastrointestinal bleeding (14.3%). The gene discussed is GPT; the disease is dermatitis.